Reply.ai Improves Customer Service with Conversational AI Bots

Clara de Soto is Co-Founder of Reply.ai, a company that produces conversational bots for businesses to improve customer experience. In addition to being the co-founder, de Soto heads up strategy, marketing, business development, and strategic partnerships. With retail moving more and more toward embracing customer support as an extension of the sales process, de Soto sees improved conversational artificial intelligence as vital in helping businesses realize their goals.

We work with major retailers to add conversational AI to the entire customer experience,” de Soto said. “From driving revenue by engaging customers in a whole new way at the top of the funnel, to streamlining new customer onboarding for more high-ticket, complex purchased, to offsetting customer support costs by reducing high-touch, low value interactions like WISMO.”

De Soto says that their product is, “built for companies who want more than a bot, but to launch a Conversational Strategy—that adds a layer of AI to the entire customer journey.”

The internet has empowered customers more than ever before, and businesses have to improve every aspect of their business to keep customers: from improved products and services to improved customer care and support. In the ‘Amazon age’ customers demand instant, personalized attention,” de Soto said. “This forces innovation in all aspects of the way a business is run, especially in retail where the battle against inventory is constantly being waged. Personalization goes a long way but must be instilled in every aspect of how a business is run.”

The social, economic, and institutional changes taking place at internet speed is affecting businesses as much if not more than anyone else. This includes, of course, the use and programming of bots. Companies are going to have to think not only about using AI bots, but also about who will be making them in the same way they had to think about how to use social media. Companies had to adapt to the presence of social media and how it changed the way business was done.

We’re at a similar junction” de Soto said about the emergence of bots. “It’s been fascinating to watch companies mature to meet these new needs. It’s only a matter of time until we see the first Chief Bot Officers rising.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More